Metformin as an adjuvant therapy for autism
Phase 2
Recruiting
- Conditions
- Autism spectrum disorder.Autistic disorderF84.0
- Registration Number
- IRCT20090117001556N156
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Age between 5-11 years
Diagnosis of autism spectrum disorder based on DSM-V
Patients who have specific behavioral problems such as aggression, hyperactivity, unusual, and stereotyped behaviors
Exclusion Criteria
An active medical disease
Diagnosis of another psychological disorder in DSM
History of previous sensitivity and intolerance to metformin
History of seizure and liver disorders
Taking antipsychotic drugs such as Risperidone before entering the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method